These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 29696728

  • 1. Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD.
    Hartjes FJ, Vonk JM, Faiz A, Hiemstra PS, Lapperre TS, Kerstjens HAM, Postma DS, van den Berge M, Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group.
    Respirology; 2018 Nov; 23(11):1023-1031. PubMed ID: 29696728
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting.
    Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK.
    Int J Chron Obstruct Pulmon Dis; 2019 Nov; 14():1063-1073. PubMed ID: 31213788
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Nov; 11():2341-2348. PubMed ID: 27703344
    [Abstract] [Full Text] [Related]

  • 4. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER, SPIROMICS investigators.
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [Abstract] [Full Text] [Related]

  • 5. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
    Pignatti P, Visca D, Zappa M, Zampogna E, Saderi L, Sotgiu G, Centis R, Migliori GB, Spanevello A.
    BMC Pulm Med; 2024 May 19; 24(1):247. PubMed ID: 38764008
    [Abstract] [Full Text] [Related]

  • 6. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging.
    De Backer J, Vos W, Vinchurkar S, Van Holsbeke C, Poli G, Claes R, Salgado R, De Backer W.
    J Aerosol Med Pulm Drug Deliv; 2015 Apr 19; 28(2):88-99. PubMed ID: 25004168
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population.
    Vestbo J, Vogelmeier CF, Small M, Siddall J, Fogel R, Kostikas K.
    Int J Chron Obstruct Pulmon Dis; 2019 Apr 19; 14():853-861. PubMed ID: 31114183
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Kunz LI, Ten Hacken NH, Lapperre TS, Timens W, Kerstjens HA, van Schadewijk A, Vonk JM, Sont JK, Snoeck-Stroband JB, Postma DS, Sterk PJ, Hiemstra PS, GLUCOLD Study Group.
    Eur Respir J; 2017 Jan 19; 49(1):. PubMed ID: 28049170
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD.
    Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koëter GH, Postma DS.
    Eur Respir J; 2000 Jan 19; 15(1):109-15. PubMed ID: 10678630
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HA.
    Respir Med; 2011 Dec 19; 105(12):1853-60. PubMed ID: 21802933
    [Abstract] [Full Text] [Related]

  • 15. Optimizing inhaled corticosteroid use in patients with chronic obstructive pulmonary disease: assessing blood eosinophils, neutrophil-to-lymphocyte ratio, and mortality outcomes in US adults.
    Hu HS, Wang Z, Jian LY, Zhao LM, Liu XD.
    Front Immunol; 2023 Dec 19; 14():1230766. PubMed ID: 38035096
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA, McDonald VM, Baines KJ, Wark PA, Simpson JL, Jones PW, Gibson PG.
    Int J Chron Obstruct Pulmon Dis; 2016 Dec 19; 11():1495-504. PubMed ID: 27445469
    [Abstract] [Full Text] [Related]

  • 18. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K, Paplińska-Goryca M, Nejman-Gryz P, Goryca K, Krenke R.
    COPD; 2017 Apr 19; 14(2):181-189. PubMed ID: 27983888
    [Abstract] [Full Text] [Related]

  • 19. Blood biomarkers as predictors of long-term mortality in COPD.
    Mendy A, Forno E, Niyonsenga T, Gasana J.
    Clin Respir J; 2018 May 19; 12(5):1891-1899. PubMed ID: 29227024
    [Abstract] [Full Text] [Related]

  • 20. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
    Wen Y, Reid DW, Zhang D, Ward C, Wood-Baker R, Walters EH.
    Int J Chron Obstruct Pulmon Dis; 2010 Oct 05; 5():327-34. PubMed ID: 21037956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.